Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Le Poumon Et Le Coeur|January 1, 1983
[Digitalis poisoning and severe respiratory insufficiency]P Dodemant, B Gerard, P Jacqueme, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.
Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerP Rougier, E Van Cutsem, E Bajetta, et al.
Melanoma Research|September 1, 1992
Fotemustine: an overview of its clinical activity in disseminated malignant melanomaD Khayat, M F Avril, B Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2002
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumoursA Awada, F A L M Eskens, M Piccart, et al.
British Journal of Haematology|July 1, 1997
Analysis of ETV6 and ETV6-AML1 proteins in acute lymphoblastic leukaemiaP Agape, B Gerard, H Cave, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controlsR E Frisch, R C Snow, L A Johnson, et al.
British Journal of Cancer|March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II studyE Van Cutsem, L Dirix, J-L Van Laethem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use programS Brienza, M A Bensmaïne, P Soulié, et al.
Neurology|February 11, 2012
Genotype-phenotype relationship in 2 SMA III patients with novel mutations in the Tudor domainM J Fraidakis, S Drunat, T Maisonobe, et al.
Pageof 15